Juan Eduardo Megías‐Vericat

Treatment patterns and outcomes of 2310 patients with secondary acute myeloid leukemia: a PETHEMA registry study

David Martínez‐Cuadrón, Juan Eduardo Megías‐Vericat, Josefina Serrano et al. · Blood Advances · 2021 · 61 citations · Full text

Surgical Oncology, Mixed-phenotype Acute Leukemia, Pathology +18

Snps and Taxane Toxicity in Breast Cancer Patients

Virginia Bosó, Marí­a José Herrero, Ana Santaballa et al. · Pharmacogenomics · 2014 · 51 citations

Safety and Effectiveness of Progressive Moderate-to-Vigorous Intensity Elastic Resistance Training on Physical Function and Pain in People With Hemophilia

Joaquín Calatayud, Sofía Pérez‐Alenda, Juan J. Carrasco et al. · Physical Therapy · 2020 · 40 citations · Full text

Trans-arterial chemoembolization with doxorubicin-eluting particles versus conventional trans-arterial chemoembolization in unresectable hepatocellular carcinoma: A study of effectiveness, safety and costs

Juan Eduardo Megías‐Vericat, R. García Marcos, Eduardo López Briz et al. · Radiología (English Edition) · 2015 · 36 citations

Thrombosis, Hepatology, Medicine +10

Impact of<i>ABC</i>single nucleotide polymorphisms upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia

Juan Eduardo Megías‐Vericat, Pau Montesinos, Marí­a José Herrero et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2016 · 34 citations

Hematological Malignancy, Anthracycline Uptake, Medicine +13